Nymox Pharmaceutical
NYMX
#7608
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-47.37%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - P/B ratio
P/B ratio as of October 2023 : -6.34
According to Nymox Pharmaceutical's latest financial reports the company has a price-to-book ratio of -6.34.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Nymox Pharmaceutical - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 37.9 | -117.38% |
| 2021-12-31 | -218 | -344.04% |
| 2020-12-31 | 89.3 | 96.45% |
| 2019-12-31 | 45.4 | 275.54% |
| 2018-12-31 | 12.1 | -108.43% |
| 2017-12-31 | -144 | -27.99% |
| 2016-12-31 | -199 | 289.1% |
| 2015-12-31 | -51.2 | 1392.35% |
| 2014-12-31 | -3.43 | -90.12% |
| 2013-12-31 | -34.7 | 12.29% |
| 2012-12-31 | -30.9 | -40.28% |
| 2011-12-31 | -51.8 | -35.52% |
| 2010-12-31 | -80.3 | -18.22% |
| 2009-12-31 | -98.2 | -369.1% |
| 2008-12-31 | 36.5 | -36% |
| 2007-12-31 | 57.0 | 8.19% |
| 2006-12-31 | 52.7 | 13.85% |
| 2005-12-31 | 46.3 | 30.03% |
| 2004-12-31 | 35.6 | 3.56% |
| 2003-12-31 | 34.4 | 25% |
| 2002-12-31 | 27.5 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.30 | -183.54% | 🇺🇸 USA |
 Pfizer PFE | 1.85 | -129.16% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.51 | -171.15% | 🇺🇸 USA |
 Eli Lilly LLY | 45.7 | -820.84% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 2.15 | -133.87% | 🇺🇸 USA |